If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,406.50
Bid: 1,405.00
Ask: 1,405.50
Change: -7.50 (-0.53%)
Spread: 0.50 (0.036%)
Open: 1,417.50
High: 1,418.50
Low: 1,386.50
Prev. Close: 1,414.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Circ re. Proposed Return of Cash

18 Mar 2013 12:00

RNS Number : 2355A
Persimmon PLC
18 March 2013
 

Persimmon PLC (the 'Company')

Proposed Return Of Cash To Shareholders

 

18 March 2013

 

PROPOSED RETURN OF CASH TO SHAREHOLDERS OF 75 PENCE PER ORDINARY SHARE BY MEANS OF A B/C SHARE SCHEME

In February 2012, the Company announced a strategy which aims to return £1.9 billion (£6.20 per share) of surplus capital to shareholders over 9½ years ending in 2021, whilst at the same time building a stronger, larger business.

Further to the 2012 Final Results announcement on 25 February 2013, the Company announces that it is today posting a circular (the "Circular") to its Shareholders containing details of a proposed 75 pence per share (approximately £227 million in aggregate) return of cash to Shareholders (the "Return of Cash"). The proposed 75 pence per share cash return is the first payment under the Capital Return Plan.

The Circular includes a notice convening a General Meeting of the Company to be held on the same day as the Annual General Meeting, on 18 April 2013, to approve the Return of Cash.

The Board proposes to effect the Return of Cash through a bonus issue of B Shares and/or C Shares which is intended to enable Shareholders, subject to applicable overseas restrictions, to elect to receive their Return of Cash proceeds as either a return of capital (the "Capital Option (B Shares)") or as dividend income (the "Income Option (C Shares)") or any combination of the two.

Under this proposed Return of Cash, referred to as a 'B/C share scheme', and subject to Shareholder approval being obtained, for every one existing Ordinary Share held at 6.00 pm on 19 April 2013, 75 pence is to be returned to Shareholders through the issue to them of either one B Share, which will be redeemed by the Company for 75 pence, or one C Share, on which a dividend of 75 pence will be paid, after which the C Share will be automatically reclassified as a Deferred Share and subsequently repurchased by the Company for an aggregate consideration of one penny and then cancelled.

The special resolution to approve the Return of Cash will also adopt new amended articles of association of the Company that incorporate the terms of the B Shares, C Shares and Deferred Shares in accordance with the B/C share scheme. These are further described in the Circular.

The expected timetable of the proposed Return of Cash is as follows:

·; the proposed Return of Cash is conditional upon Shareholder approval, which will be sought at a General Meeting of the Company to be held at 12.30 pm on 18 April 2013;

·; the latest time and date for receipt of Shareholders' forms of proxy and CREST proxy instructions to vote on the resolution to approve the Return of Cash is 12.30 pm on 16 April 2013;

·; the record date for the entitlement to B Shares and/or C Shares under the Return of Cash is 6.00 pm on 19 April 2013;

·; the latest time and date for receipt of Shareholders' Forms of Election in respect of the Capital Option (B Shares) and Income Option (C Shares) is 11.00 am on 3 May 2013;

·; payments are expected to be made to Shareholders and CREST accounts are expected to be credited by 28 June 2013.

If the Resolution is not passed at the General Meeting, the Return of Cash will not proceed.

The Circular will be available later today on the Company's website, www.corporate.persimmonhomes.com, and will be submitted to the National Storage Mechanism, where it will be available for inspection at www.Morningstar.co.uk/uk/nsm.

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

This announcement does not constitute, or form part of, an offer to sell or the solicitation of an offer to subscribe for any securities, nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issue or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

None of the B Shares, C Shares or Deferred Shares have been or will be registered under the US Securities Act or the state securities laws of the United States and none of them may be offered or sold in the United States unless pursuant to a transaction which has been registered under the US Securities Act and/or relevant state securities laws or which is not subject to the registration requirements of the US Securities Act or such laws, either because of an exemption therefrom or otherwise.

None of the U.S. Securities and Exchange Commission, any state securities commission in the United States, nor any other securities commission or regulatory authority has approved or disapproved of the securities described in this document or determined if this document is truthful, complete or accurate. Any representation to the contrary is a criminal offence in the United States.

Enquiries:

Persimmon plc Mike Farley, Group Chief ExecutiveMike Killoran, Group Finance Director

 

Tel: +44 (0) 1904 642199

Citigate Dewe Rogerson

Simon Rigby

Kevin Smith

Lindsay Noton

 

Tel: +44 (0) 20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CIRFVLFFXXFEBBV
Date   Source Headline
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.